Approval for the rithron-xr coronary stent system.  The device is indicated for use in patients eligible for balloon angioplasty with symptomatic ischemic heart disease characterized by discrete de novo coronary artery lesions with reference vessel diameter from >=3.0 mm or <=4.0 mm and target lesion length <=20.0 mm.